Reviva Pharmaceuticals Holdings Inc (RVPH)
1.87
-0.27
(-12.62%)
USD |
NASDAQ |
May 10, 16:00
1.87
0.00 (0.00%)
After-Hours: 20:00
Reviva Pharmaceuticals Holdings Shares Outstanding: 27.92M for April 4, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
April 04, 2024 | 27.92M |
March 11, 2024 | 27.92M |
February 16, 2024 | 27.92M |
January 29, 2024 | 27.92M |
December 31, 2023 | 27.92M |
November 20, 2023 | 27.92M |
November 09, 2023 | 22.65M |
September 30, 2023 | 22.65M |
September 29, 2023 | 22.65M |
August 11, 2023 | 22.65M |
June 30, 2023 | 22.65M |
June 14, 2023 | 22.65M |
May 11, 2023 | 20.63M |
March 31, 2023 | 20.45M |
March 27, 2023 | 20.45M |
March 14, 2023 | 20.45M |
December 31, 2022 | 20.45M |
November 10, 2022 | 20.44M |
October 03, 2022 | 20.44M |
September 30, 2022 | 20.44M |
September 08, 2022 | 20.44M |
September 06, 2022 | 18.47M |
August 12, 2022 | 18.13M |
Date | Value |
---|---|
June 30, 2022 | 15.13M |
May 11, 2022 | 15.13M |
March 31, 2022 | 15.13M |
March 10, 2022 | 15.13M |
March 01, 2022 | 15.13M |
January 20, 2022 | 15.13M |
December 31, 2021 | 14.43M |
November 09, 2021 | 13.98M |
October 11, 2021 | 13.89M |
September 30, 2021 | 13.39M |
August 12, 2021 | 13.39M |
June 30, 2021 | 13.39M |
June 01, 2021 | 13.37M |
May 26, 2021 | 9.232M |
May 13, 2021 | 9.232M |
April 15, 2021 | 9.232M |
March 31, 2021 | 9.232M |
March 11, 2021 | 9.232M |
March 01, 2021 | 9.232M |
January 14, 2021 | 9.232M |
December 31, 2020 | 9.232M |
December 28, 2020 | 9.232M |
December 15, 2020 | 9.232M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
9.232M
Minimum
Dec 15 2020
27.92M
Maximum
Nov 20 2023
17.46M
Average
16.63M
Median
Shares Outstanding Benchmarks
AbbVie Inc | 1.766B |
ABVC BioPharma Inc | 10.56M |
Sutro Biopharma Inc | 76.92M |
Flora Growth Corp | 10.68M |
Journey Medical Corp | 19.97M |